DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Varespladib methyl is an investigational drug.
There have been 4 clinical trials for Varespladib methyl. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Syndrome, Acute Coronary Syndrome, and Renal Insufficiency. The leading clinical trial sponsors are Anthera Pharmaceuticals and [disabled in preview].
Recent Clinical Trials for Varespladib methyl
|A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function||Anthera Pharmaceuticals||Phase 1|
|Study to Assess the Metabolism and Elimination of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects||Anthera Pharmaceuticals||Phase 1|
|VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome||Anthera Pharmaceuticals||Phase 3|